Registry for patients with pancreatic diseases
Registry of Subjects Affected by Pancreatic Disease and Evaluated at the Pancreas Institute of Verona
This study is collecting health information from people with pancreatic diseases to help improve understanding and treatment options for these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Azienda Ospedaliera Universitaria Integrata Verona Academic / other |
| Locations | 1 site (Verona) |
| Trial ID | NCT03807687 on ClinicalTrials.gov |
What this trial studies
This clinical data registry collects comprehensive information about the health status and healthcare experiences of individuals affected by various pancreatic diseases, including both inflammatory and neoplastic conditions. The registry gathers a wide range of data, including demographic, clinical, biochemical, radiological, pharmacological, and genetic information, as well as audio and video recordings from surgical procedures. This data will be utilized for both prospective and retrospective studies to enhance understanding and treatment of pancreatic disorders.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals diagnosed with any type of pancreatic disease, including both inflammatory and neoplastic conditions.
Not a fit: Patients who are physically or mentally unable to provide consent will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could improve the understanding and management of pancreatic diseases, leading to better patient outcomes.
How similar studies have performed: While this registry approach is common in observational studies, the specific focus on pancreatic diseases may provide novel insights that have not been extensively explored in previous studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions) Exclusion Criteria: * physically or mentally inability to provide consent
Where this trial is running
Verona
- AOUI Verona — Verona, Italy (Recruiting)
Study contacts
- Principal investigator: Claudio Bassi, Prof — AOUI Verona
- Study coordinator: Erica Secchettin
- Email: erica.secchettin@aovr.veneto.it
- Phone: +390458126254
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.